Loading organizations...
§ Private Profile · New York City, NY, USA
AI-powered healthcare intelligence platform simplifying collaboration for pharma, biotech, and medtech teams with clinician profiles and analytics.
G LNK has raised $500K across 1 funding round.
Key people at G LNK.
G LNK was founded in 2024 by Rayan Ghandour (Founder) and Raouf Abujaber (Founder).
G LNK has raised $500K in total across 1 funding round.
G LNK is a London, England-based healthcare intelligence platform that utilizes artificial intelligence to streamline collaboration between medical professionals and life sciences organizations. The company provides commercial and strategy teams with instant access to a database containing over 9.2 million clinician profiles and 20 million curated user records. Operating with a core team of two employees across London and New York, the platform integrates prescribing analytics, claims data, and fair market value intelligence to assist clients across the pharma, biotech, and medtech sectors. By leveraging proprietary matching models, the system helps accelerate drug development and commercialization efforts while ensuring compliant engagement and delivering hospital intelligence data. Prior to its scheduled dissolution in September 2025, the enterprise exhibited its technology at major industry conferences including the CPHI event. G LNK was founded in 2024 by Rayan Ghandour and Alexander Gregoriades.
Key people at G LNK.
G LNK is an AI-driven platform designed to streamline collaboration, compliance, and networking within the healthcare ecosystem, primarily connecting pharmaceutical companies, researchers, and healthcare professionals. It automates complex processes such as fair market value assessments, candidate identification, and compliance management, enabling more efficient and cost-effective engagement between pharma companies and medical experts. The platform offers integrated project management tools, AI-powered matchmaking, and personalized career advancement opportunities, addressing fragmented workflows and enhancing strategic partnerships in medical research and healthcare innovation[1][2][5].
For an investment firm perspective, G LNK operates in the healthcare technology sector with a mission to optimize healthcare professional engagement and research collaboration through AI automation. Its investment philosophy would likely focus on scalable AI solutions that reduce inefficiencies and regulatory risks in healthcare. By simplifying pharma-HCP interactions, G LNK positively impacts the startup ecosystem by accelerating innovation adoption and improving resource allocation in life sciences[1][2].
From a portfolio company viewpoint, G LNK builds an AI platform that serves pharmaceutical companies, researchers, and healthcare professionals. It solves the problem of inefficient, manual, and compliance-heavy processes in healthcare collaboration and engagement. The company shows growth momentum by leveraging advanced AI technologies and expanding its network globally, facilitating faster, compliant, and more strategic connections across the healthcare industry[1][2][3].
---
G LNK was co-founded by Raouf and Rayan, who have a longstanding professional relationship dating back over a decade, including collaboration as researchers at the University of Chicago. The idea emerged from firsthand experience with the costly and manual processes pharma companies use to engage healthcare professionals, particularly around compliance and compensation. Recognizing that billions were wasted annually on outdated methods, they developed an AI-powered platform to automate and streamline these workflows. Early traction involved demonstrating significant cost savings and compliance improvements for pharma clients, validating the platform’s value proposition[2].
The company is based in Paris, France, and has evolved its focus from basic networking tools to a comprehensive AI-driven ecosystem that integrates data analytics, project management, and strategic partnership facilitation across healthcare sectors[1][3].
---
---
G LNK rides the growing trend of AI integration in healthcare, particularly in optimizing collaboration and compliance within the life sciences ecosystem. The timing is critical as pharmaceutical companies face increasing regulatory scrutiny and rising costs in engaging healthcare professionals. Market forces such as digital transformation, demand for real-world evidence, and the need for efficient research partnerships favor platforms like G LNK that unify data, automate workflows, and enhance transparency.
By simplifying complex interactions and providing actionable insights, G LNK influences the broader ecosystem by accelerating innovation adoption, improving research productivity, and enabling more strategic resource allocation in healthcare. Its platform supports the shift toward data-driven, AI-enabled healthcare collaboration, which is becoming essential for competitive advantage in pharma and biotech[1][2][3].
---
Looking ahead, G LNK is poised to expand its AI capabilities and deepen integration with healthcare data sources to further enhance predictive analytics and personalized networking. Trends such as increased regulatory complexity, the rise of decentralized clinical trials, and growing demand for real-world data will shape its evolution. The company’s influence is likely to grow as it becomes a critical infrastructure layer connecting pharma, researchers, and healthcare professionals globally.
Future developments may include broader adoption across healthcare verticals, enhanced interoperability with electronic health records and research databases, and expanded career development tools for healthcare professionals. G LNK’s mission to streamline collaboration and compliance positions it well to drive efficiency and innovation in healthcare, tying back to its core goal of accelerating life-changing treatments through smarter connections[1][2][3][5].
G LNK has raised $500K across 1 funding round. Most recently, it raised $500K Seed in March 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 1, 2025 | $500K Seed | — | Dell Technologies Capital, TEN Eleven Ventures, Y Combinator, Assaf Rappaport, Deepak Jeevan Kumar, Jodi Sherman Jahic, Stephen Pankhurst | Announced |
G LNK was founded in 2024 by Rayan Ghandour (Founder) and Raouf Abujaber (Founder).
G LNK has raised $500K in total across 1 funding round.
G LNK's investors include Dell Technologies Capital, Ten Eleven Ventures, Y Combinator, Assaf Rappaport, Deepak Jeevan Kumar, Jodi Sherman Jahic, Stephen Pankhurst.
